Showing results (91-100 of 245) with videos related to

Sort By:
Pageof 25
Clinical Genitourinary Cancer|April 13, 2016
Phase II Study of Pazopanib and Paclitaxel in Patients With Refractory Urothelial CancerSujata Narayanan, Anthony Lam, Ulka Vaishampayan, et al.
Cancer|May 20, 2008
Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinomaEric Jonasch, Walter M Stadler, Ronald M Bukowski, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 28, 2011
Not every subseptate uterus requires surgical correction to reduce poor reproductive outcomeLi-Hong Pang, Mu-Jun Li, Mingqing Li, et al.
Experimental & Molecular Medicine|July 5, 2022
Hypoxia-hindered methylation of PTGIS in endometrial stromal cells accelerates endometriosis progression by inducing CD16- NK-cell differentiationHaiyan Peng, Lichun Weng, Shating Lei, et al.
International Orthopaedics|September 24, 2015
Cementless total hip arthroplasty in advanced tuberculosis of the hipMin Zeng, Yihe Hu, Yi Leng, et al.
Cell Death & Disease|December 2, 2016
1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosisChunyan Wei, Jie Mei, Lingli Tang, et al.
International Journal of Clinical and Experimental Pathology|April 4, 2014
Opposing role of JNK-p38 kinase and ERK1/2 in hydrogen peroxide-induced oxidative damage of human trophoblast-like JEG-3 cellsChuanling Tang, Jing Liang, Jinfeng Qian, et al.
International Journal of Biological Macromolecules|August 8, 2025
Harnessing the CD16-PI3Kγ axis in peritoneal CD14hi macrophages: A transformative approach to endometriosis managementChunyan Wei, Yukai Liu, Siman Chen, et al.
Investigational New Drugs|April 7, 2010
Oral enzastaurin in prostate cancer: a two-cohort phase II trial in patients with PSA progression in the non-metastatic castrate state and following docetaxel-based chemotherapy for castrate metastatic diseaseRobert Dreicer, Jorge Garcia, Maha Hussain, et al.
BMC Urology|June 24, 2020
Physician preferences for non-metastatic castration-resistant prostate cancer treatmentSandy Srinivas, Ateesha F Mohamed, Sreevalsa Appukkuttan, et al.
Pageof 25